Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) said its wholly-owned subsidiary Disruptive Battery Corp, together with US joint venture partner PureBiotic AIR Corp, continues to advance the certification and regulatory registrations of its products.
In a statement, Manganese X Energy CEO Martin Kepman said: "We continue to evolve our misting solution for the mitigation of pathogens, including coronavirus (COVID-19).”
“Research is showing positive efficacy. We are now moving towards additional certifications, including applying for US Food and Drug Administration (FDA) approval," he added.
READ: Manganese X subsidiary joint-venture partner PureBiotic AIR receives positive results from Mist Solutions testing
In one of the latest rounds of testing conducted by Virginia State University (VSU), the priority was documenting the risk reduction on an important range of pathogens and biofilm, including COVID-19, utilizing the company’s PureBiotic Mist Solution on surfaces, in addition to air.
Manganese X said work has “progressed on the deconstruction of biofilm,” which is regarded by the Center for Disease Control (CDC), to be a key factor in 80% of all infections.
The “deconstruction of biofilm reduces the risk of infection from pathogenic bacteria and viruses, including the SARS-CoV-2 virus,” which is behind the pandemic, added the company.
Manganese X said the firm has employed “additional resources” to expedite the number of FDA, Environmental Protection Agency (EPA), and other registrations and certifications currently in progress. PureBiotics is also expanding the company's trademark registrations which have already been granted in the Americas, Europe, and China.
The work is being coordinated by the PureBiotic CEO Lino G Morris, and the company’s regulatory attorney K Steinman, who formerly worked for the US government in Washington DC in the regulatory field. He has been the company's legal lead in these matters for some time and handles all the domestic and international trademark registrations for the company. He is also working with the EPA and FDA on the company's new registrations.
In Canada, the company has roped in Toronto-based Dicentra Regulatory Consultants initially to help with work related to Health Canada. They also have a great deal of expertise with the FDA. For “specialized situations,” the company said it has other Washington-based agencies, all coordinated by Steinman to “expedite registrations,” said the company.
Manganese X observed that there’s great interest in its current FDA registration for its PureBiotic Solution because of the expected “speed to completion.” This specific registration will “increase our market expansion opportunities,” said the company.
Meanwhile, NSF approval and registrations have already been obtained for a number of products, said the company. In a nutshell, the NSF mark assures consumers, retailers and regulators that certified products have been rigorously tested to comply with all standard requirements.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive